These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2419935)

  • 1. [Monoamine metabolite levels in cerebrospinal fluid of schizophrenic patients].
    Imazu Y; Kobayashi K; Kawabata M; Shohmori T
    Seishin Shinkeigaku Zasshi; 1985; 87(9):634-42. PubMed ID: 2419935
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
    Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
    Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAO activity, csf amine metabolites, and drug-free improvement in schizophrenia.
    Van Kammen DP; Marder SR; Murphy DL; Bunney WE
    Am J Psychiatry; 1978 May; 135(5):567-9. PubMed ID: 645949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction.
    Stelmasiak Z
    Neuropatol Pol; 1982; 20(1-2):97-105. PubMed ID: 6191248
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levels of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid in patients with focal cerebral ischemia].
    Chavko M; Kehr J; Vasková M; Eiben E
    Cesk Neurol Neurochir; 1989 Oct; 52(6):403-8. PubMed ID: 2483951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on dopamine metabolite in cerebrospinal fluid of schizophrenics and epilepsics].
    Jiang S; Chen X; Liao W
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):155-6. PubMed ID: 10681831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low cerebrospinal fluid homovanillic acid-5-hydroxyindoleacetic acid ratio predicts clozapine efficacy: a replication.
    Risch SC; Lewine RR
    Arch Gen Psychiatry; 1993 Aug; 50(8):670. PubMed ID: 7688212
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in AIDS dementia complex.
    Candito M; Durant J; Gurle V; Chambon P; Dellamonica P
    AIDS; 1995 Sep; 9(9):1100-1. PubMed ID: 8527086
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebrospinal fluid amine metabolites in affective illness and schizophrenia: clinical and pharmacological studies.
    Goodwin FK; Post RM
    Psychopharmacol Commun; 1975; 1(6):641-53. PubMed ID: 1224017
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography.
    Fri CG; Wiesel FA; Sedvall G
    Life Sci; 1974 Jun; 14(12):2469-80. PubMed ID: 4549970
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF creatinine in schizophrenia.
    Swahn CG; Sedvall G
    Biol Psychiatry; 1988 Mar; 23(6):586-94. PubMed ID: 2451543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are monoamine metabolites in cerebrospinal fluid worth measuring?
    Potter WZ; Manji HK
    Arch Gen Psychiatry; 1993 Aug; 50(8):653-6. PubMed ID: 7688211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.